Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Perpetua Medical

5,26 SEK

+0,38 %

Mindre end 1K følgere

PERP B

First North Stockholm

Medical Equipment & Services

Health Care

Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
Sammenligne
+0,38 %
+17,15 %
+5,41 %
+18,20 %
+22,90 %
+3,14 %
-90,09 %
-94,57 %
-97,41 %

Perpetua Medical is a serial acquirer of profitable companies in the healthcare sector. The company's operations are conducted according to a decentralized ownership model, where operations and decision-making take place in independent subsidiaries. The name Perpetua (Latin for 'eternal') reflects the strategy of acquiring and long-term ownership of companies without any fixed time horizon. Until 2023, the company had a different business focus and was called Pharmacolog. The head office is in Uppsala.

Læs mere
Markedsværdi
23,78 mio. SEK
Aktieomsætning
605,5 SEK
Omsætning
6,94 mio.
EBIT %
-35,45 %
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
19.12
2025

Ekstraordinær generalforsamling '25

20.2
2026

Årsrapport '25

Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Selskabsmeddelelse18.6.2024, 20.15

Perpetua Medical AB: Perpetua Medical has entered a letter of intent regarding the acquisition of a majority stake in ES-Medical AB

Perpetua Medical
Selskabsmeddelelse14.6.2024, 11.15

Perpetua Medical AB: Resolutions from the Annual General Meeting 2024 in Pepetua Medcial

Perpetua Medical
Selskabsmeddelelse12.6.2024, 06.30

Perpetua Medical AB: Perpetua Medical is offered a loan facility of up to SEK 25 million

Perpetua Medical

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Selskabsmeddelelse17.5.2024, 06.30

Perpetua Medical AB: Perpetua Medical publishes interim report January - March 2024

Perpetua Medical
Selskabsmeddelelse15.5.2024, 07.30

Perpetua Medical AB: NOTICE OF ANNUAL GENERAL MEETING IN PERPETUA MEDICAL AB (PUBL)

Perpetua Medical
Selskabsmeddelelse24.4.2024, 06.30

Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) appoints Camilla Lönn as CFO

Perpetua Medical
Pressemeddelelse23.4.2024, 06.30

Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) announces its first day of trading on Nasdaq First North under its new company name

Perpetua Medical
Selskabsmeddelelse17.4.2024, 06.30

Nolsterby Invest AB has increased its holding further in Pharmacolog

Perpetua Medical
Selskabsmeddelelse16.4.2024, 14.42

Pharmacolog: ANNOUNCEMENT FROM THE EXTRAORDINARY GENERAL MEETING OF PHARMACOLOG I UPPSALA AB ON APRIL 16, 2024

Perpetua Medical
Selskabsmeddelelse16.4.2024, 13.07

Pharmacolog publishes annual report for 2023

Perpetua Medical
Selskabsmeddelelse8.4.2024, 06.30

Nolsterby Invest AB has increased its holding in Pharmacolog

Perpetua Medical
Selskabsmeddelelse4.4.2024, 06.30

Pharmacolog announces the appointment of Anders Hedlund as interim CEO

Perpetua Medical
Selskabsmeddelelse14.3.2024, 09.20

Pharmacolog: NOTICE TO EXTRAORDINARY GENERAL MEETING IN PHARMACOLOG I UPPSALA AB (PUBL)

Perpetua Medical
Selskabsmeddelelse14.3.2024, 09.15

Pharmacolog provides update on new business direction and proposes name change

Perpetua Medical
Selskabsmeddelelse1.3.2024, 11.55

Pharmacolog announces upcoming change in management

Perpetua Medical
Selskabsmeddelelse27.2.2024, 10.38

Warrants of series TO3 were subscribed to approximately 90.4 percent and Pharmacolog receives approximately SEK 2.3 million

Perpetua Medical
Selskabsmeddelelse20.2.2024, 13.10

Major shareholder in Pharmacolog exercises warrants of series TO3 for at least approximately SEK 0.54 million

Perpetua Medical
Selskabsmeddelelse20.2.2024, 07.30

The last day of trading with warrants of series TO3 in Pharmacolog is today, February 20, 2024

Perpetua Medical
Selskabsmeddelelse16.2.2024, 07.30

Year-end bulletin Pharmacolog 2023

Perpetua Medical
Selskabsmeddelelse15.2.2024, 07.30

Pharmacolog investigates the possibilities for a new business direction

Perpetua Medical
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.